Skip to main content

Publication

2018

Chipollini J, Necchi A, Spiess PE. 2018. Outcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention. Eur Urol. 74:241–242. doi:10.1016/j.eururo.2018.04.025.
Pozo K, Zahler S, Ithimatsu K, Carter A, Telange R, Wang S, Pfragner R, Fujimoto J, Grubbs E, Takahashi M, et al. 2018. Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer, Oncotarget, 9: 37662-37675.
Shroff RT, Yarchoan M, O’Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Parkinson R, Subbiah V, et al. 2018. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 118:e2. doi:10.1038/bjc.2017.418.